Wednesday, February 10, 2010, 5:27am EST - Canadian Markets open in 4 hours and 3 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Fifth Third Mid Cap Growth Inv C (FCMCX)

On Feb 9: 6.27 USD  Up 0.08 (1.29%)  
MORE ON FCMCX
Quotes
HereSummary
Charts
News & Info
Fund
Analyst
FIFTH THIRD MID CAP GROWTH CL C Delayed quote dataEdit
Net Asset Value: 6.27
Trade Time: Feb 9
Change: Up 0.08 (1.29%)
Prev Close: 6.27
YTD Return*: 6.87%
Net Assets*: 870.00K
Yield*: N/A
* As of 31-Dec-07
Fifth Third Mid Cap Growth Inv C (FCMCX)
3m  6m  1y  2y  5y  max 
 Add FCMCX to Portfolio   Download Data

HEADLINES
Small Cap Biotech Companies Being Replaced by Government NIH Funding as Source of Profits for Medical Diagnostics Companies According to Industry Experts
Wall Street Transcript (Mon, Jul 13)
More Headlines for FCMCX...

31-Dec-07
FUND BASICS
Morningstar Overall Rating: 2 stars
Total Assets: 870.00K
Category: Mid-Cap Growth
Total Expense Ratio: 2.09%
Fund Profile - Holdings


31-Dec-07
PERFORMANCE & RISK
YTD Return: 6.87%
5y Avg Return: 13.36%
Rank in Category (ytd): 77
% Rank in Category (ytd): 7.96%
Beta (3y): 1.31
Morningstar Risk Rating: Average
Performance Details - Risk Details

FUND SUMMARY
The investment seeks capital growth; income is a secondary consideration. The fund normally invests at least 80% of assets in common stocks of mid-cap companies. Mid-cap companies are defined as those companies included in the Russell Mid-Cap Growth index and companies with similar market capitalizations. It may invest up to 20% of assets in common stocks of large-cap companies, small-cap companies, convertible securities and debt securities that pay interest. The fund seeks to outperform the Russell Mid-Cap Growth index over rolling five-year periods.
Fund Profile


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices